Table I.
Demographic details of the patients included in the study (n=80)
| Details of patients | HL, n (%) | Aggressive NHL, n (%) | Indolent NHL, n (%) |
|---|---|---|---|
| Total number of cases | 37 | 30 | 13 |
| Median age (yr) | 23 | 47 | 55 |
| Range (yr) | 3-62 | 7-85 | 40-79 |
| Sex | |||
| Male | 26 (70.3) | 22 (73.3) | 9 (69.2) |
| Female | 11 (29.7) | 8 (26.7) | 4 (30.8) |
| B-symptoms | |||
| Fever | 21 (56.8) | 17 (56.7) | 5 (38.5) |
| Weight loss | 16 (43.2) | 17 (56.7) | 5 (38.5) |
| Night sweats | 18 (48.6) | 13 (43.3) | 5 (38.5) |
| Clinical organ involvement | |||
| Lymphadenopathy | 37 (100) | 23 (76.7) | 11 (84.6) |
| Hepatomegaly | 15 (35.1) | 6 (20) | 3 (23.1) |
| Splenomegaly | 11 (29.7) | 7 (23.3) | 3 (23.1) |
| Site of involvement | |||
| Nodal | 28 (75.7) | 15 (50) | 7 (53.8) |
| Extranodal | 0 | 6 (20) | 1 (7.7) |
| Nodal/extranodal | 9/37 (24.3) | 9/30 (30) | 5/13 (38.5) |
| Ann Arbor stage | |||
| I | 2 (5.4) | 6 (20) | 1 (7.7) |
| II | 9 (24.3) | 1 (3.3) | 1 (7.7) |
| III | 6 (16.2) | 5 (16.7) | 1 (7.7) |
| IV | 20 (54.1) | 18 (60) | 10 (76.9) |
| Cell type | |||
| B-cell | 37 (100) | 24 (80) | 12 (92.3) |
| T-cell | 0 | 5 (16.7) | 1 (7.7) |
| NK/T-cell | 0 | 1 (3.3) | 0 |
HL, Hodgkin lymphoma; NHL, non-HL